skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > quinolines > 4-(3,4-dihydro-2h-quinolin-1-ylsulfonyl)-n-[3-(dimethylamino)propyl]-n-(6-ethyl-1,3-benzothiazol-2-yl)benzamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > quinolines > 4-(3,4-dihydro-2h-quinolin-1-ylsulfonyl)-n-[3-(dimethylamino)propyl]-n-(6-ethyl-1,3-benzothiazol-2-yl)benzamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > quinolines > 4-(3,4-dihydro-2h-quinolin-1-ylsulfonyl)-n-[3-(dimethylamino)propyl]-n-(6-ethyl-1,3-benzothiazol-2-yl)benzamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > quinolines > 4-(3,4-dihydro-2h-quinolin-1-ylsulfonyl)-n-[3-(dimethylamino)propyl]-n-(6-ethyl-1,3-benzothiazol-2-yl)benzamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > quinolines > 4-(3,4-dihydro-2h-quinolin-1-ylsulfonyl)-n-[3-(dimethylamino)propyl]-n-(6-ethyl-1,3-benzothiazol-2-yl)benzamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > quinolines > 4-(3,4-dihydro-2h-quinolin-1-ylsulfonyl)-n-[3-(dimethylamino)propyl]-n-(6-ethyl-1,3-benzothiazol-2-yl)benzamide

Preferred term

4-(3,4-dihydro-2h-quinolin-1-ylsulfonyl)-n-[3-(dimethylamino)propyl]-n-(6-ethyl-1,3-benzothiazol-2-yl)benzamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C30H34N4O3S2

inchi

  • InChI=1S/C30H34N4O3S2/c1-4-22-12-17-26-28(21-22)38-30(31-26)33(19-8-18-32(2)3)29(35)24-13-15-25(16-14-24)39(36,37)34-20-7-10-23-9-5-6-11-27(23)34/h5-6,9,11-17,21H,4,7-8,10,18-20H2,1-3H3

inchikey

  • WXUASCZMBUYHBV-UHFFFAOYSA-N

mass

  • 562.749

monoisotopicmass

  • 562.20723

smiles

  • CCC1=CC2=C(C=C1)N=C(S2)N(CCCN(C)C)C(=O)C3=CC=C(C=C3)S(=O)(=O)N4CCCC5=CC=CC=C54

subset

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:104079

Download this concept: